Sign In
Free Newsletter
Mar 22, 2024
Loyal Receives $45M Series B Financing to Develop of FDA-Approved Dog Lifespan Extension Drug
Loyal, a biotech company pioneering longevity drugs for dogs, recently announced that it has successfully completed its Series B funding round, securing $45 million in investment. The round was led by Bain Capital Ventures. This brings total funding raised by Loyal to more than $125 million since its founding in 2019 and includes a $12 […]
